Cargando…

CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer

CD47 is overexpressed in many human cancers, its level positively correlates with tumor invasion and metastasis. However, it is largely unknown whether CD47 overexpression drives metastasis and how CD47 lead to tumor metastasis in non-small cell lung cancer (NSCLC). In this study, we analyzed NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hui, Wang, Jianxin, Kong, Xiaodan, Li, Encheng, Liu, Yuanbin, Du, Xiaohui, Kang, Zhijie, Tang, Ying, Kuang, Yanbin, Yang, Zhihui, Zhou, Youwen, Wang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944213/ https://www.ncbi.nlm.nih.gov/pubmed/27411490 http://dx.doi.org/10.1038/srep29719

Ejemplares similares

M2 macrophages promote NSCLC metastasis by upregulating CRYAB
por: Guo, Zhe, et al.
Publicado: (2019)

A Novel Technique to Detect EGFR Mutations in Lung Cancer
por: Liu, Yuanbin, et al.
Publicado: (2016)

CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis
por: Gao, Lu, et al.
Publicado: (2016)

CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals
por: Li, Yang, et al.
Publicado: (2022)

Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
por: Lian, Shu, et al.
Publicado: (2019)

EGFR‐Induced and c‐Src‐Mediated CD47 Phosphorylation Inhibits TRIM21‐Dependent Polyubiquitylation and Degradation of CD47 to Promote Tumor Immune Evasion
por: Du, Linyong, et al.
Publicado: (2023)

Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis
por: Qu, Shuang, et al.
Publicado: (2022)

Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice
por: Li, Yang, et al.
Publicado: (2020)

The CD24(+) cell subset promotes invasion and metastasis in human osteosarcoma
por: Zhou, Zhenhua, et al.
Publicado: (2020)

CD47 on artificial structures
por: Schütz, Christian
Publicado: (2015)

Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis
por: Hu, Tuo, et al.
Publicado: (2020)

Anti-CD47 Antibody Enhances the Efficacy of Chemotherapy in Patients with Gastric Cancer Liver Metastasis
por: Liu, Zhaorui, et al.
Publicado: (2023)

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
por: Wu, Hao, et al.
Publicado: (2021)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Role of CD47 in Hematological Malignancies
por: Eladl, Entsar, et al.
Publicado: (2020)

Targeting CD47 for cancer immunotherapy
por: Jiang, Zhongxing, et al.
Publicado: (2021)

CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway
por: Liu, Xuejian, et al.
Publicado: (2019)

The Invasion and Metastasis Promotion Role of CD97 Small Isoform in Gastric Carcinoma
por: Liu, Daren, et al.
Publicado: (2012)

Construction of Exosomes that Overexpress CD47 and Evaluation of Their Immune Escape
por: Ben, Xin-Yu, et al.
Publicado: (2022)

Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine models
por: Rivera, Armando, et al.
Publicado: (2015)

Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer
por: Wei, Song, et al.
Publicado: (2022)

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
por: Betancur, Paola A., et al.
Publicado: (2017)

Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer
por: Myint, Zin W., et al.
Publicado: (2023)

Glutathione peroxidase 4‐dependent glutathione high‐consumption drives acquired platinum chemoresistance in lung cancer‐derived brain metastasis
por: Liu, Wenwen, et al.
Publicado: (2021)

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
por: Shi, Rui, et al.
Publicado: (2020)

Significance of CD47 expression in gastric cancer
por: Sudo, Tomoya, et al.
Publicado: (2017)

Regulation of CD47 expression in cancer cells
por: Huang, Can-Yu, et al.
Publicado: (2020)

CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions
por: Leclair, Pascal, et al.
Publicado: (2020)

CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer
por: Lau, Asa P. Y., et al.
Publicado: (2023)

Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis
por: Liao, Cheng-Gong, et al.
Publicado: (2022)

CD47 differentially regulates white and brown fat function
por: Norman-Burgdolf, Heather, et al.
Publicado: (2020)

Targeting CD47 as a Novel Immunotherapy for Breast Cancer
por: Chen, Can, et al.
Publicado: (2022)

Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo
por: Chiang, Zu-Chian, et al.
Publicado: (2022)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Promising alternatives of CD47 monoclonal antibody: an injectable degradable hydrogel loaded with PQ912 for postoperative immunotherapy effectively blocks CD47-SIRPα signal
por: Li, Chang, et al.
Publicado: (2022)

Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
por: Zhang, Xuyao, et al.
Publicado: (2019)

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity
por: Zhang, Bin, et al.
Publicado: (2022)

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
por: Sun, Jennifer, et al.
Publicado: (2020)

Increased lymphocyte activation and atherosclerosis in CD47-deficient mice
por: Engelbertsen, Daniel, et al.
Publicado: (2019)

Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
por: Xu, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tcpnpn9tg4dbok4ckrrv1e3ccb